logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
O

Oncology and Therapy

IF3.2
Papers358
Citations622
Journal Papers 355
Publication Date
delete
Real-World First-Line Treatment Characteristics and Physician Drivers in Advanced/Metastatic Non–Small Cell Lung Cancer, PD-L1 ≥ 50%, and without Actionable Genomic Alterations
deleteOncology and Therapy
IF3.2
delete2026-10-03
delete0
deleteOAAI
deleteDwight H. Owen; Martin Sebastian; Hirotsugu Kenmotsu; Shilpa Viswanathan; Shivani K. Mhatre; Inderjit K. Dhillon; Cosmina Hogea; Siwen Ding; Cameron Forshaw; Hollie Bailey; Delvys Rodríguez-Abreu
deleteShare
deleteSave
Neoplasms Metastatic to the Larynx: A Systematic Review
deleteOncology and Therapy
IF3.2
delete2026-09-18
delete0
deleteOAAI
deleteClaudia Montenegro; Fatima-Ezzahra Nassih; Cesare Piazza; Alfio Ferlito
deleteShare
deleteSave
Early-Onset Colorectal Cancer: Clinical and Molecular Features with Emerging Insights from Comprehensive Genomic Profiling
deleteOncology and Therapy
IF3.2
delete2026-09-16
delete0
deleteOAAI
deleteAmanda Nogueira; Jennifer Brondon; Konstantin Haradinov; Srinivasan Gopalakrishnan; Krane Huang; Debasri Mukherjee; Smita Agarwal; Kyle C. Strickland; Laura Vidal; Chinmayee Joshi; Rebecca Brookes; Rajeev Prasad; Soma Das; Arun K. Mankan; Archana Munje; Begona de las Heras; Brajendra Prasad Singh; Daniel Gandia; Shakti Ramkissoon; Fahmi Sabr Raza; Isagani Chico; Sharadchandra K. Prasad; Judith Perez; Anumeha Prasad; Debashis Sarker; Julien Taieb; Kamal S. Saini
deleteShare
deleteSave
Real-World Testing Landscape and Costs of Companion Diagnostics and Comprehensive Genomic Profiling Across Nine Solid Tumors in Japan: A 10-Year Analysis
deleteOncology and Therapy
IF3.2
delete2026-09-05
delete0
deleteOAAI
deleteKuniko Sunami; Sona-Sanae Aoyagi; Masashi Mikami; Kanae Togo
deleteShare
deleteSave
A Qualitative Study of Patient and Caregiver Perspectives on Locally Advanced Head and Neck Cancer in the United States
deleteOncology and Therapy
IF3.2
delete2026-09-04
delete0
deleteOAAI
deleteEsther Yu; Veronica Ashton; OluYemisi Falope; Toby Hanna; Teresa Kessell; Matt Scott; Denise D’Andrea; Maureen Tucker O’Malley; Rebecca Genin
deleteShare
deleteSave
Patient-Reported Outcome Instruments in Non-Muscle-Invasive Bladder Cancer (NMIBC): A Systematic Review
deleteOncology and Therapy
IF3.2
delete2026-08-25
delete0
deleteOAAI
deleteIngolf Griebsch; Sunil Shrestha; Carolyn C. Gotay; John L. Gore; Fran Curtis; Andrew Bottomley
deleteShare
deleteSave
Exceptional Cure of a Patient with Progressive Advanced Squamous-Cell Lung Cancer after Selenite Treatment followed by Chemotherapy: A Case Report
deleteOncology and Therapy
IF3.2
delete2026-08-18
delete0
deleteOAAI
deleteOla Brodin; Carlos Fernandez Moro; Mattias Hedman; Ozan Aricak; Tímea Szekerczés; Per Grybäck; Mikael Björnstedt
deleteShare
deleteSave
Publisher Correction: Ceralasertib Plus Durvalumab in Chinese Patients with Advanced Solid Tumors: A Nonrandomized Clinical Trial
deleteOncology and Therapy
IF3.2
delete2026-08-17
delete0
deleteOAAI
deleteYuping Sun; Jia Zhong; Huiwen Sun; Graeme Parr; Edit Lukacs; Daniel Slade; Yizhao Zhou; Xiaoyu Ren; David Kirk; Aleksandra Kmieciak; Tingting Yao; Jie Wang
deleteShare
deleteSave
Ceralasertib Plus Durvalumab in Chinese Patients with Advanced Solid Tumors: A Nonrandomized Clinical Trial
deleteOncology and Therapy
IF3.2
delete2026-07-28
delete0
deleteOAAI
deleteYuping Sun; Jia Zhong; Huiwen Sun; Graeme Parr; Edit Lukacs; Daniel Slade; Yizhao Zhou; Xiaoyu Ren; David Kirk; Aleksandra Kmieciak; Tingting Yao; Jie Wang
deleteShare
deleteSave
Clinicians’ Perspectives on the Impact of Different Attributes of Androgen Receptor Pathway Inhibitors on Prostate Cancer Treatment Preferences and Compliance in Mexico
deleteOncology and Therapy
IF3.2
delete2026-07-23
delete0
deleteOAAI
deleteMario Escobar Gómez; Ana Maria Rodríguez-Leboeuf; Selene Camargo-Correa; Ida Caterina García-Appendini; Arti Dhar; Isabela Rivas; Juan Guillermo Ariza; Pedro A. Madero-Morales
deleteShare
deleteSave
A Comprehensive Mapping of Real-World Studies and Data Sources for Oncology in China: Insights into Landscape, Challenges, and Future Direction
deleteOncology and Therapy
IF3.2
delete2026-07-14
delete0
deleteOAAI
deleteYaqi Jia; Yanbing Li; Siyan Zhan; Jeff Jianfei Guo; Yan-Jun Zhang; Ziheng Guo; Xian Cao
deleteShare
deleteSave
IMMPACT-MM: Insights into Multiple Myeloma Patient Outcomes following Early-Line Cilta-cel Treatment
deleteOncology and Therapy
IF3.2
delete2026-06-28
delete0
deleteOAAI
deleteSridevi Rajeeve; Saurabh P. Nagar; Sabyasachi Ghosh; Victoria Alegria; Justin Hayne; Bruno Emond; Jessica Maitland; Zaina P. Qureshi; Larry D. Anderson
deleteShare
deleteSave
Podcast on the Emerging Role of PD-(L)1/VEGF Bispecific Antibodies in the Evolving Advanced Renal Cell Carcinoma Treatment Landscape
deleteOncology and Therapy
IF3.2
delete2026-06-26
delete0
deleteOAAI
deleteBrian I. Rini; Benjamin Garmezy
deleteShare
deleteSave
Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC): An Aggressive Disease Course and Limitations for Personalized Oncology
deleteOncology and Therapy
IF3.2
delete2026-06-25
delete0
deleteOAAI
deleteCeline Oanæs; Herish Garresori; Dordi Lea; Marcus T. T. Roalsø; Torjan M. Haslerud; Cato Brede; Kjetil Søreide
deleteShare
deleteSave
Real-World Outcomes Among Medicare Beneficiaries Treated with Bruton Tyrosine Kinase Inhibitors for Treatment-Naïve CLL
deleteOncology and Therapy
IF3.2
delete2026-06-22
delete0
deleteOAAI
deleteDaniel A. Ermann; Deborah M. Stephens; Xiaoliang Wang; Irene Varghese; Heidi De Souza; Caitlin Sheetz; Qianhong Fu; Gregory A. Maglinte; Rhys Williams; Erlene K. Seymour; Derrick van Beuge; Mazyar Shadman; Ryan Jacobs
deleteShare
deleteSave
Real-World Actionability Analysis of Comprehensive Genomic Profiling Versus Single/Small-Gene Panels
deleteOncology and Therapy
IF3.2
delete2026-06-21
delete0
deleteOAAI
deletePaul Spin; Bela Bapat; Chad Moretz; Robert Dumanois; Adrienne M. Gilligan; Mostafa Shokoohi; Emily Borgundvaag; John Fox; Carlo Bifulco; David Bartlett
deleteShare
deleteSave
Abemaciclib in HR+, HER2− Breast Cancer: A Narrative Review of the Clinical Evidence
deleteOncology and Therapy
IF3.2
delete2026-06-15
delete0
deleteOAAI
deleteMiguel Martin; Alexandru Rosca; Alexandra Searles Vitko; Monique Coersmeyer; Katheryn Moreira; Huiping Li; Erica L. Mayer
deleteShare
deleteSave
Evaluation of Drug–Drug Interactions Using Drug-PIN® in Patients Receiving Avelumab Maintenance for Advanced Urothelial Carcinoma: Evidence from the MALVA Study (Meet-URO 25)
deleteOncology and Therapy
IF3.2
delete2026-06-13
delete0
deleteOAAI
deleteGiandomenico Roviello; Mattia Alberto Di Civita; Daniele Santini; Elisabetta Gambale; Lidia Strigari; Simone Scagnoli; Laura Pappalardo; Andrea Torchia; Andrea Botticelli; Serena Pillozzi; Lorenzo Antonuzzo
deleteShare
deleteSave
Beyond the BCG Paradox: Biological Rationale and Clinical Evidence for Combining Intravesical BCG with Immune Checkpoint Inhibitors in High-Risk Non-muscle-Invasive Bladder Cancer
deleteOncology and Therapy
IF3.2
delete2026-06-11
delete0
deleteOAAI
deleteMichele Musone; Biagio Barone; Stefano Chianese; Paolo Conforti; Antonio Madonna; Silvestro Imperatore; Fabrizio Dinacci; Raffaele Balsamo; Giuseppe Lucarelli; Roberto Falabella; Vincenzo Francesco Caputo; Antonio Luigi Pastore; Andrea Fuschi; Matteo Ferro; Lorenzo Romano; Marco Fabiano; Celeste Manfredi; Gian Maria Busetto; Valerio Santarelli; Francesco Del Giudice; Felice Crocetto
deleteShare
deleteSave
Publisher Correction: Perioperative Treatment Patterns for Muscle-Invasive Bladder Cancer Patients Undergoing Radical Cystectomy in the Adjuvant Immunotherapy Era: A Retrospective Analysis of US Community Oncology Practice
deleteOncology and Therapy
IF3.2
delete2026-06-09
delete0
deleteOAAI
deletePatrick Squires; Ke Meng; Xiaohan Hu; Vladimir Turzhitsky; Yu-Han Kao; Jennifer Stuart; Chethan Ramamurthy; Haojie Li; Ronac Mamtani
deleteShare
deleteSave